BIB ProShares Ultra Nasdaq Biotechnology
110.98
5.96 (+5.68%)
Fiyat tarihi: Oct 09, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Önceki Kapanış | 105.02 | Günlük Aralık | 106.78 – 111.39 |
| 52 Haftalık Aralık | 62.72 – 126.40 | Hacim | 7.33K |
| Ort. Hacim | 10.96K | AUM | $93.2M (Oct 12, 2026) |
| Gider Oranı | 1.19% | Getiri (TTM) | 0.20% |
| NAV | 110.96 | Prim/İskonto | +0.02% gösterge niteliğinde |
| Başlangıç | Apr 07, 2010 | Varlıklar | 274 |
| İhraççı | ProShares | Borsa | NASDAQ |
| Kategori | Biotech | Takip Edilen Endeks | Kaynak veride belirtilmemiş |
| CUSIP | 74347R214 | ISIN | US74347R2141 |
| Yönetim | Pasif / endeks takipçisi (ihraççı açıklamasına göre) | ||
Bu ETF hakkında
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
Fon veri sağlayıcısından alınan açıklama · tarihli profil: Oct 12, 2026.
Fiyat Grafiği
Günlük kapanış fiyatları (fiyat getirisi, toplam getiri değil). Karşılaştırma çizgileri, aralığın başlangıcından itibaren yüzde değişimine göre normalize edilir. Kaynak: Financial Modeling Prep.
Performans
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Başl.* | |
|---|---|---|---|---|---|---|---|---|---|
| Fiyat getirisi | -1.62% | +7.83% | +36.05% | +39.11% | +69.07% | +31.89% | +4.90% | +9.61% | +17.73% |
| Toplam getiri | -1.62% | +7.83% | +36.05% | +39.12% | +69.38% | +33.08% | +5.47% | +9.91% | +17.93% |
* Yıllık bazda. Toplam getiri, temettü düzeltmeli fiyat serisini kullanır (dağıtımlar yeniden yatırılır); fiyat getirisi ise düzeltilmemiş kapanış fiyatlarını kullanır. Şu tarihe kadar performans: Oct 09, 2026. Geçmiş performans gelecekteki sonuçları garanti etmez.
Ücretler
| Net gider oranı | 1.19% | 10.000 $ yatırımın yıllık maliyeti | $119.00 |
Yalnızca gösterge amaçlı hesaplama: gider oranı × 10.000 $. İşlem maliyetleri, alış/satış spreadleri, vergiler ve yatırım değerindeki değişiklikler dahil değildir. Brüt ve net gider ayrıntıları ile varsa ücret muafiyetleri izahnamede yer almaktadır.
Varlıklar
Varlıklar itibarıyla Oct 10, 2026 · veri sağlayıcısından gelen portföy raporlama tarihi; portföy kalemleri gerçek zamanlı pozisyonlar değildir. 256 veri tabanındaki satır sayısı.
| # | Varlık | Ticker | Ağırlık | Hisseler | Piyasa Değeri |
|---|---|---|---|---|---|
| 1 | Net Other Assets (Liabilities) | — | 19.91% | 18.56M | $18.6M |
| 2 | PROSHARES GENIUS MNY MKT ETF | IQMM | 18.26% | 170.00K | $17.0M |
| 3 | GILEAD SCIENCES INC | GILD | 5.20% | 32.07K | $4.8M |
| 4 | AMGEN INC | AMGN | 4.86% | 10.92K | $4.5M |
| 5 | VERTEX PHARMACEUTICALS INC | VRTX | 4.72% | 8.62K | $4.4M |
| 6 | MODERNA INC | MRNA | 3.70% | 15.34K | $3.5M |
| 7 | REGENERON PHARMACEUTICALS | REGN | 3.11% | 3.88K | $2.9M |
| 8 | ILLUMINA INC | ILMN | 1.73% | 5.80K | $1.6M |
| 9 | REVOLUTION MEDICINES INC | RVMD | 1.68% | 8.23K | $1.6M |
| 10 | BIOGEN INC | BIIB | 1.37% | 5.68K | $1.3M |
| 11 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1.28% | 5.14K | $1.2M |
| 12 | ROIVANT SCIENCES LTD | ROIV | 1.06% | 27.75K | $983.4K |
| 13 | ROYALTY PHARMA PLC- CL A | RPRX | 1.04% | 17.11K | $973.8K |
| 14 | UNITED THERAPEUTICS CORP | UTHR | 0.97% | 1.65K | $905.0K |
| 15 | INCYTE CORP | INCY | 0.94% | 7.79K | $878.3K |
| 16 | ARGENX SE - ADR | ARGX | 0.93% | 1.05K | $864.6K |
| 17 | GUARDANT HEALTH INC | GH | 0.93% | 5.16K | $863.3K |
| 18 | INSMED INC | INSM | 0.91% | 8.39K | $843.9K |
| 19 | VIATRIS INC | VTRS | 0.84% | 44.12K | $778.3K |
| 20 | MEDPACE HOLDINGS INC | MEDP | 0.70% | 1.07K | $656.1K |
| 21 | EXELIXIS INC | EXEL | 0.61% | 9.52K | $569.8K |
| 22 | NEUROCRINE BIOSCIENCES INC | NBIX | 0.60% | 3.90K | $556.2K |
| 23 | JAZZ PHARMACEUTICALS PLC | JAZZ | 0.58% | 2.49K | $544.7K |
| 24 | ASCENDIS PHARMA A/S | ASND | 0.58% | 2.37K | $542.1K |
| 25 | SUMMIT THERAPEUTICS INC | SMMT | 0.58% | 30.65K | $539.1K |
| 26 | BRIDGEBIO PHARMA INC | BBIO | 0.54% | 7.70K | $503.3K |
| 27 | BEONE MEDICINES LTD-ADR | ONC | 0.52% | 1.38K | $488.1K |
| 28 | HALOZYME THERAPEUTICS INC | HALO | 0.52% | 4.36K | $481.4K |
| 29 | TEMPUS AI INC-CL A | TEM | 0.51% | 6.74K | $477.9K |
| 30 | BIONTECH SE-ADR | BNTX | 0.46% | 4.45K | $431.3K |
| 31 | IMMUNITYBIO INC | IBRX | 0.46% | 40.72K | $427.9K |
| 32 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.45% | 888 | $418.9K |
| 33 | VAXCYTE INC | PCVX | 0.44% | 5.72K | $408.0K |
| 34 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.44% | 7.44K | $407.5K |
| 35 | TWIST BIOSCIENCE CORP | TWST | 0.44% | 2.55K | $407.1K |
| 36 | KRYSTAL BIOTECH INC | KRYS | 0.40% | 1.14K | $377.0K |
| 37 | 10X GENOMICS INC-CLASS A | TXG | 0.40% | 4.62K | $372.4K |
| 38 | KYMERA THERAPEUTICS INC | KYMR | 0.39% | 3.19K | $359.0K |
| 39 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.38% | 2.49K | $357.3K |
| 40 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.37% | 5.43K | $340.5K |
| 41 | AXSOME THERAPEUTICS INC | AXSM | 0.36% | 2.01K | $338.7K |
| 42 | CYTOKINETICS INC | CYTK | 0.36% | 5.34K | $336.0K |
| 43 | SANOFI-ADR | SNY | 0.36% | 8.28K | $331.9K |
| 44 | CARIS LIFE SCIENCES INC | CAI | 0.35% | 10.86K | $322.4K |
| 45 | SPYRE THERAPEUTICS INC | SYRE | 0.31% | 3.39K | $290.2K |
| 46 | IONIS PHARMACEUTICALS INC | IONS | 0.31% | 6.38K | $289.1K |
| 47 | PRAXIS PRECISION MEDICINES I | PRAX | 0.30% | 1.07K | $278.8K |
| 48 | AMNEAL PHARMACEUTICALS INC | AMRX | 0.29% | 13.38K | $266.4K |
| 49 | ALKERMES PLC | ALKS | 0.28% | 6.45K | $261.7K |
| 50 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.27% | 17.40K | $254.4K |
| 51 | IMMUNOVANT INC | IMVT | 0.26% | 7.93K | $241.8K |
| 52 | GRAIL INC | GRAL | 0.26% | 1.72K | $241.2K |
| 53 | KODIAK SCIENCES INC | KOD | 0.26% | 2.41K | $241.1K |
| 54 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.26% | 2.65K | $240.1K |
| 55 | LIGAND PHARMACEUTICALS | LGND | 0.25% | 766 | $231.2K |
| 56 | CG ONCOLOGY INC | CGON | 0.23% | 3.40K | $217.3K |
| 57 | ERASCA INC | ERAS | 0.23% | 13.44K | $215.4K |
| 58 | MIRUM PHARMACEUTICALS INC | MIRM | 0.23% | 2.49K | $214.5K |
| 59 | ORUKA THERAPEUTICS INC | ORKA | 0.22% | 2.54K | $208.9K |
| 60 | PTC THERAPEUTICS INC | PTCT | 0.22% | 3.21K | $207.4K |
| 61 | COGENT BIOSCIENCES INC | COGT | 0.22% | 6.67K | $206.6K |
| 62 | CRISPR THERAPEUTICS AG | CRSP | 0.21% | 3.71K | $198.3K |
| 63 | SCHOLAR ROCK HOLDING CORP | SRRK | 0.21% | 4.68K | $197.4K |
| 64 | ABIVAX SA-ADR | ABVX | 0.21% | 2.20K | $193.6K |
| 65 | DEFINIUM THERAPEUTICS INC | DFTX | 0.20% | 5.16K | $190.5K |
| 66 | TRAVERE THERAPEUTICS INC | TVTX | 0.20% | 3.62K | $188.7K |
| 67 | EDGEWISE THERAPEUTICS INC | EWTX | 0.17% | 4.17K | $163.0K |
| 68 | INDIVIOR PHARMACEUTICALS INC | INDV | 0.17% | 4.53K | $162.5K |
| 69 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.17% | 6.13K | $162.4K |
| 70 | ABCELLERA BIOLOGICS INC | ABCL | 0.17% | 12.45K | $156.2K |
| 71 | TANGO THERAPEUTICS INC | TNGX | 0.17% | 6.48K | $154.2K |
| 72 | RELAY THERAPEUTICS INC | RLAY | 0.16% | 8.42K | $150.5K |
| 73 | KINIKSA PHARMACEUTICALS INTE | KNSA | 0.16% | 1.85K | $148.0K |
| 74 | VERACYTE INC | VCYT | 0.15% | 3.09K | $139.7K |
| 75 | GENMAB A/S -SP ADR | GMAB | 0.15% | 3.73K | $138.1K |
| 76 | AMYLYX PHARMACEUTICALS INC | AMLX | 0.15% | 4.82K | $135.7K |
| 77 | XENON PHARMACEUTICALS INC | XENE | 0.15% | 3.72K | $135.6K |
| 78 | IDEAYA BIOSCIENCES INC | IDYA | 0.14% | 3.71K | $133.9K |
| 79 | ACADIA PHARMACEUTICALS INC | ACAD | 0.14% | 6.62K | $130.9K |
| 80 | TARSUS PHARMACEUTICALS INC | TARS | 0.14% | 1.77K | $129.2K |
| 81 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.14% | 4.83K | $128.4K |
| 82 | DENALI THERAPEUTICS INC | DNLI | 0.13% | 6.14K | $119.4K |
| 83 | DYNE THERAPEUTICS INC | DYN | 0.13% | 7.17K | $119.4K |
| 84 | ENLIVEN THERAPEUTICS INC | ELVN | 0.12% | 2.81K | $115.4K |
| 85 | PRECIGEN INC | PGEN | 0.12% | 13.75K | $107.4K |
| 86 | BEAM THERAPEUTICS INC | BEAM | 0.11% | 3.97K | $102.0K |
| 87 | NEWAMSTERDAM PHARMA CO NV | — | 0.11% | 4.59K | $99.1K |
| 88 | MBX BIOSCIENCES INC | MBX | 0.11% | 1.85K | $98.5K |
| 89 | SUPERNUS PHARMACEUTICALS INC | SUPN | 0.10% | 2.23K | $95.3K |
| 90 | DISC MEDICINE INC | IRON | 0.10% | 1.48K | $91.5K |
| 91 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.10% | 2.24K | $90.1K |
| 92 | RECURSION PHARMACEUTICALS-A | RXRX | 0.10% | 20.57K | $89.7K |
| 93 | ADMA BIOLOGICS INC | ADMA | 0.10% | 8.61K | $89.1K |
| 94 | NURIX THERAPEUTICS INC | NRIX | 0.10% | 3.99K | $89.1K |
| 95 | AURINIA PHARMACEUTICALS INC | AUPH | 0.09% | 5.11K | $85.1K |
| 96 | BIOCRYST PHARMACEUTICALS INC | BCRX | 0.09% | 9.82K | $83.9K |
| 97 | PHARVARIS NV | PHVS | 0.09% | 2.70K | $83.9K |
| 98 | VERA THERAPEUTICS INC | VERA | 0.09% | 2.77K | $82.7K |
| 99 | NOVAVAX INC | NVAX | 0.09% | 6.34K | $80.8K |
| 100 | STRUCTURE THERAPEUTICS INC | GPCR | 0.09% | 3.15K | $80.4K |
| 101 | MINERALYS THERAPEUTICS INC | MLYS | 0.09% | 3.40K | $79.4K |
| 102 | VERICEL CORP | VCEL | 0.08% | 1.97K | $78.9K |
| 103 | FORTREA HOLDINGS INC | FTRE | 0.08% | 3.65K | $76.1K |
| 104 | VIR BIOTECHNOLOGY INC | VIR | 0.08% | 6.50K | $76.1K |
| 105 | ALVOTECH SA | ALVO | 0.08% | 12.99K | $75.1K |
| 106 | XERIS BIOPHARMA HOLDINGS INC | XERS | 0.08% | 7.00K | $73.4K |
| 107 | AGIOS PHARMACEUTICALS INC | AGIO | 0.08% | 2.29K | $73.0K |
| 108 | SAREPTA THERAPEUTICS INC | SRPT | 0.08% | 4.06K | $72.4K |
| 109 | TREVI THERAPEUTICS INC | TRVI | 0.08% | 5.47K | $72.2K |
| 110 | INTELLIA THERAPEUTICS INC | NTLA | 0.08% | 5.38K | $70.4K |
| 111 | XENCOR INC | XNCR | 0.08% | 2.86K | $70.3K |
| 112 | ZYMEWORKS INC | ZYME | 0.08% | 2.73K | $70.3K |
| 113 | UROGEN PHARMA LTD | URGN | 0.07% | 1.88K | $69.2K |
| 114 | SEPTERNA INC | SEPN | 0.07% | 1.79K | $68.8K |
| 115 | ZENAS BIOPHARMA INC | ZBIO | 0.07% | 2.50K | $68.3K |
| 116 | ABSCI CORP | ABSI | 0.07% | 6.59K | $67.0K |
| 117 | LEGEND BIOTECH CORP-ADR | LEGN | 0.07% | 3.54K | $65.9K |
| 118 | PERSONALIS INC | PSNL | 0.07% | 4.10K | $65.6K |
| 119 | NOVOCURE LTD | NVCR | 0.07% | 4.47K | $65.2K |
| 120 | ANI PHARMACEUTICALS INC | ANIP | 0.07% | 882 | $65.2K |
| 121 | OCULAR THERAPEUTIX INC | OCUL | 0.07% | 8.44K | $63.6K |
| 122 | COMPASS PATHWAYS PLC | CMPS | 0.07% | 5.14K | $61.7K |
| 123 | STOKE THERAPEUTICS INC | STOK | 0.07% | 2.48K | $61.3K |
| 124 | ETON PHARMACEUTICALS INC | ETON | 0.07% | 1.10K | $60.6K |
| 125 | UNIQURE NV | QURE | 0.06% | 2.67K | $60.2K |
| 126 | INNOVIVA INC | INVA | 0.06% | 2.77K | $58.9K |
| 127 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.06% | 3.79K | $58.6K |
| 128 | SYNDAX PHARMACEUTICALS INC | SNDX | 0.06% | 3.43K | $58.3K |
| 129 | MAZE THERAPEUTICS INC | MAZE | 0.06% | 2.13K | $57.9K |
| 130 | RAPPORT THERAPEUTICS INC | RAPP | 0.06% | 1.84K | $56.5K |
| 131 | TAYSHA GENE THERAPIES INC | TSHA | 0.06% | 12.52K | $56.2K |
| 132 | GH RESEARCH PLC | GHRS | 0.06% | 2.64K | $55.7K |
| 133 | PACIRA BIOSCIENCES INC | PCRX | 0.06% | 1.53K | $55.6K |
| 134 | OMEROS CORP | OMER | 0.06% | 2.78K | $55.1K |
| 135 | INHIBRX BIOSCIENCES INC | INBX | 0.06% | 565 | $53.7K |
| 136 | IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.06% | 1.78K | $52.3K |
| 137 | ANAPTYSBIO INC | ANAB | 0.06% | 1.14K | $52.2K |
| 138 | REPLIMUNE GROUP INC | REPL | 0.05% | 3.62K | $48.6K |
| 139 | ORIC PHARMACEUTICALS INC | ORIC | 0.05% | 3.98K | $47.7K |
| 140 | TYRA BIOSCIENCES INC | TYRA | 0.05% | 2.29K | $45.7K |
| 141 | VOR BIOPHARMA INC | VOR | 0.05% | 2.27K | $45.2K |
| 142 | BICARA THERAPEUTICS INC | BCAX | 0.05% | 2.54K | $44.5K |
| 143 | FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.05% | 1.37K | $43.7K |
| 144 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.05% | 1.63K | $43.5K |
| 145 | JANUX THERAPEUTICS INC | JANX | 0.05% | 2.35K | $43.2K |
| 146 | ZAI LAB LTD-ADR | ZLAB | 0.05% | 1.71K | $42.8K |
| 147 | MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.05% | 5.72K | $42.6K |
| 148 | HARROW INC | HROW | 0.05% | 1.44K | $42.3K |
| 149 | MANNKIND CORP | MNKD | 0.04% | 12.35K | $40.6K |
| 150 | CASTLE BIOSCIENCES INC | CSTL | 0.04% | 1.17K | $40.4K |
| 151 | MEIRAGTX HOLDINGS PLC | MGTX | 0.04% | 3.69K | $39.4K |
| 152 | SAVARA INC | SVRA | 0.04% | 7.89K | $38.8K |
| 153 | CULLINAN THERAPEUTICS INC | CGEM | 0.04% | 2.47K | $38.4K |
| 154 | KURA ONCOLOGY INC | KURA | 0.04% | 3.42K | $36.2K |
| 155 | ALUMIS INC | ALMS | 0.04% | 4.97K | $35.6K |
| 156 | RIGEL PHARMACEUTICALS INC | RIGL | 0.04% | 718 | $35.2K |
| 157 | GRIFOLS SA-ADR | GRFS | 0.04% | 4.69K | $35.0K |
| 158 | CORVUS PHARMACEUTICALS INC | CRVS | 0.04% | 3.23K | $34.0K |
| 159 | MONTE ROSA THERAPEUTICS INC | GLUE | 0.04% | 3.28K | $33.8K |
| 160 | SANA BIOTECHNOLOGY INC | SANA | 0.03% | 11.50K | $32.1K |
| 161 | ARBUTUS BIOPHARMA CORP | ABUS | 0.03% | 7.60K | $32.1K |
| 162 | ARRIVENT BIOPHARMA INC | AVBP | 0.03% | 1.89K | $31.7K |
| 163 | ARDELYX INC | ARDX | 0.03% | 9.57K | $31.4K |
| 164 | PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% | 811 | $31.1K |
| 165 | GERON CORP | GERN | 0.03% | 24.68K | $30.2K |
| 166 | ANNEXON INC | ANNX | 0.03% | 7.28K | $29.3K |
| 167 | CANDEL THERAPEUTICS INC | CADL | 0.03% | 2.94K | $29.2K |
| 168 | MESOBLAST LTD- SPON ADR | MESO | 0.03% | 2.01K | $28.8K |
| 169 | SOLID BIOSCIENCES INC | SLDB | 0.03% | 4.12K | $28.3K |
| 170 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.03% | 2.12K | $28.3K |
| 171 | DESIGN THERAPEUTICS INC | DSGN | 0.03% | 2.40K | $28.0K |
| 172 | PACIFIC BIOSCIENCES OF CALIF | PACB | 0.03% | 11.94K | $27.8K |
| 173 | PRIME MEDICINE INC | PRME | 0.03% | 6.97K | $27.8K |
| 174 | COLLEGIUM PHARMACEUTICAL INC | COLL | 0.03% | 1.25K | $27.6K |
| 175 | OMNIAB INC | OABI | 0.03% | 5.58K | $26.8K |
| 176 | OLEMA PHARMACEUTICALS INC | OLMA | 0.03% | 3.36K | $26.3K |
| 177 | WAVE LIFE SCIENCES INC | WVE | 0.03% | 7.57K | $26.2K |
| 178 | AURA BIOSCIENCES INC | AURA | 0.03% | 3.98K | $26.1K |
| 179 | ZEVRA THERAPEUTICS INC | ZVRA | 0.03% | 2.28K | $26.0K |
| 180 | IRONWOOD PHARMACEUTICALS INC | IRWD | 0.03% | 6.35K | $24.2K |
| 181 | AQUESTIVE THERAPEUTICS INC | AQST | 0.02% | 4.82K | $23.0K |
| 182 | PHATHOM PHARMACEUTICALS INC | PHAT | 0.02% | 3.11K | $22.5K |
| 183 | CORMEDIX INC | CRMD | 0.02% | 2.99K | $22.1K |
| 184 | ACLARIS THERAPEUTICS INC | ACRS | 0.02% | 5.66K | $21.7K |
| 185 | CYTOMX THERAPEUTICS INC | CTMX | 0.02% | 8.37K | $21.5K |
| 186 | SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% | 2.37K | $21.1K |
| 187 | REGENXBIO INC | RGNX | 0.02% | 2.54K | $20.5K |
| 188 | PUMA BIOTECHNOLOGY INC | PBYI | 0.02% | 1.98K | $20.4K |
| 189 | NEUROGENE INC | NGNE | 0.02% | 769 | $20.3K |
| 190 | EVOLUS INC | EOLS | 0.02% | 2.54K | $19.6K |
| 191 | ALTIMMUNE INC | ALT | 0.02% | 7.47K | $19.5K |
| 192 | ALLOGENE THERAPEUTICS INC | ALLO | 0.02% | 13.27K | $19.4K |
| 193 | ARVINAS INC | ARVN | 0.02% | 2.51K | $19.2K |
| 194 | ALPHA TEKNOVA INC | TKNO | 0.02% | 2.06K | $18.2K |
| 195 | KAMADA LTD | KMDA | 0.02% | 2.22K | $17.9K |
| 196 | SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% | 1.80K | $17.8K |
| 197 | TECTONIC THERAPEUTIC INC | TECX | 0.02% | 751 | $17.5K |
| 198 | PROTHENA CORP PLC | PRTA | 0.02% | 1.97K | $17.4K |
| 199 | EDITAS MEDICINE INC | EDIT | 0.02% | 5.90K | $17.1K |
| 200 | LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.02% | 572 | $17.0K |
| 201 | CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% | 1.27K | $16.9K |
| 202 | ARS PHARMACEUTICALS INC | SPRY | 0.02% | 3.82K | $16.2K |
| 203 | ATEA PHARMACEUTICALS INC | AVIR | 0.02% | 3.08K | $15.9K |
| 204 | KYVERNA THERAPEUTICS INC | KYTX | 0.02% | 2.38K | $15.2K |
| 205 | ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.02% | 1.09K | $15.0K |
| 206 | C4 THERAPEUTICS INC | CCCC | 0.02% | 4.73K | $14.9K |
| 207 | ENANTA PHARMACEUTICALS INC | ENTA | 0.02% | 1.12K | $14.0K |
| 208 | AUTOLUS THERAPEUTICS PLC | AUTL | 0.01% | 7.71K | $13.9K |
| 209 | ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% | 2.31K | $13.7K |
| 210 | CABALETTA BIO INC | CABA | 0.01% | 6.51K | $12.6K |
| 211 | QUANTUM-SI INC | QSI | 0.01% | 7.64K | $11.7K |
| 212 | EYEPOINT INC | EYPT | 0.01% | 3.31K | $11.3K |
| 213 | BIOAGE LABS INC | BIOA | 0.01% | 1.76K | $11.2K |
| 214 | FULCRUM THERAPEUTICS INC | FULC | 0.01% | 2.93K | $11.0K |
| 215 | ROCKET PHARMACEUTICALS INC | RCKT | 0.01% | 4.22K | $10.8K |
| 216 | LARIMAR THERAPEUTICS INC | LRMR | 0.01% | 3.99K | $10.7K |
| 217 | VANDA PHARMACEUTICALS INC | VNDA | 0.01% | 2.32K | $10.6K |
| 218 | LEXEO THERAPEUTICS INC | LXEO | 0.01% | 3.15K | $10.2K |
| 219 | UPSTREAM BIO INC | UPB | 0.01% | 2.10K | $9.9K |
| 220 | IMMUNEERING CORP - CLASS A | IMRX | 0.01% | 2.48K | $9.8K |
| 221 | AC IMMUNE SA | ACIU | 0.01% | 3.91K | $9.8K |
| 222 | LIFECORE BIOMEDICAL INC | LFCR | 0.01% | 1.45K | $9.4K |
| 223 | KEROS THERAPEUTICS INC | KROS | 0.01% | 762 | $9.1K |
| 224 | SIGA TECHNOLOGIES INC | SIGA | 0.01% | 2.76K | $9.1K |
| 225 | SIONNA THERAPEUTICS INC | SION | 0.01% | 1.74K | $8.5K |
| 226 | ENTRADA THERAPEUTICS INC | TRDA | 0.01% | 1.50K | $8.5K |
| 227 | LYELL IMMUNOPHARMA INC | LYEL | 0.01% | 941 | $8.2K |
| 228 | INVIVYD INC | IVVD | 0.01% | 11.32K | $8.2K |
| 229 | BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% | 1.79K | $7.0K |
| 230 | PEPGEN INC | PEPG | 0.01% | 2.66K | $7.0K |
| 231 | PYXIS ONCOLOGY INC | PYXS | 0.01% | 3.20K | $6.5K |
| 232 | COHERUS ONCOLOGY INC | CHRS | 0.01% | 5.93K | $6.4K |
| 233 | JYONG BIOTECH LTD | MENS | 0.01% | 2.92K | $6.1K |
| 234 | NOVABRIDGE BIOSCIENCES | NBP | 0.01% | 4.31K | $6.0K |
| 235 | CODEXIS INC | CDXS | 0.01% | 4.21K | $5.9K |
| 236 | VOYAGER THERAPEUTICS INC | VYGR | 0.01% | 2.37K | $5.8K |
| 237 | ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% | 3.56K | $5.3K |
| 238 | TENAYA THERAPEUTICS INC | TNYA | 0.01% | 8.61K | $5.0K |
| 239 | FOGHORN THERAPEUTICS INC | FHTX | 0.00% | 2.28K | $4.6K |
| 240 | LENZ THERAPEUTICS INC | LENZ | 0.00% | 1.21K | $4.4K |
| 241 | HUMACYTE INC | HUMA | 0.00% | 10.67K | $4.3K |
| 242 | BLACK DIAMOND THERAPEUTICS I | BDTX | 0.00% | 2.21K | $4.0K |
| 243 | AARDVARK THERAPEUTICS INC | AARD | 0.00% | 841 | $4.0K |
| 244 | RANI THERAPEUTICS HOLDINGS-A | RANI | 0.00% | 4.43K | $3.5K |
| 245 | NEUMORA THERAPEUTICS INC | NMRA | 0.00% | 7.22K | $3.4K |
| 246 | GOSSAMER BIO INC | GOSS | 0.00% | 235 | $2.2K |
| 247 | CARIBOU BIOSCIENCES INC | CRBU | 0.00% | 4.12K | $1.9K |
| 248 | THIRD HARMONIC BIO INC | THRD | 0.00% | 1.66K | $0.00 |
| 249 | CARTESIAN THERAPEUTICS-CVR | — | 0.00% | 9.79K | $0.00 |
| 250 | NASDAQ Bio Index SWAP BNP Paribas | — | 0.00% | 3.80K | $0.00 |
| 251 | NASDAQ Biotechnology Index SWAP Citibank NA | — | 0.00% | 4.72K | $0.00 |
| 252 | NASDAQ Biotechnology Index SWAP Goldman Sachs… | — | 0.00% | 2.64K | $0.00 |
| 253 | NASDAQ Biotechnology Index SWAP UBS AG | — | 0.00% | 629 | $0.00 |
| 254 | NASDAQ Biotechnology Index SWAP Societe Generale | — | 0.00% | 2.51K | $0.00 |
| 255 | NASDAQ Biotechnology Index SWAP Bank of America… | — | 0.00% | 4.08K | $0.00 |
| 256 | COHERUS ONCOLOGY INC COMMON STOCK USD | — | 0.00% | 5.36K | $0.00 |
Bir ticker'a tıklayarak o hisse senedini tutan tüm ETF'leri görün.
Sektör Dağılımı
Coğrafi Yatırım Dağılımı
Ülke ağırlıkları veri sağlayıcının raporladığı şekliyle gösterilmektedir. Gelişmiş/gelişmekte olan/sınır piyasası etiketleri Metodoloji sayfasındaki sınıflandırmayı izler. Döviz korumalı: Fon adında herhangi bir kur koruması belirtilmemiş.
Dağıtımlar
| Getiri (TTM) | 0.20% | Ödenen (son 12 ay) | $0.2243 |
| Sıklık | Semi-Annual | SEC getirisi | Veri kaynağımız tarafından sağlanmamıştır; ihraççı sayfasına bakın |
| Son temettü tarihi | Sep 23, 2026 | Son ödeme | $0.0826 (Sep 29, 2026) |
| 1 Yıllık Büyüme | -74.46% | 3Y / 5Y Büyüme (yıllıklandırılmış) | +124.40% / — |
| Temettü kesim tarihi | Kayıt | Ödeme tarihi | Tutar |
|---|---|---|---|
| Sep 23, 2026 | Sep 23, 2026 | Sep 29, 2026 | $0.0826 |
| Mar 25, 2026 | Mar 25, 2026 | Mar 31, 2026 | $0.0071 |
| Dec 24, 2025 | Dec 24, 2025 | Dec 31, 2025 | $0.1346 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 30, 2025 | $0.1805 |
| Jun 25, 2025 | Jun 25, 2025 | Jul 01, 2025 | $0.1706 |
| Mar 26, 2025 | Mar 26, 2025 | Apr 01, 2025 | $0.1309 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 31, 2024 | $0.3964 |
| Sep 25, 2024 | Sep 25, 2024 | Oct 02, 2024 | $0.1529 |
| Jun 26, 2024 | Jun 26, 2024 | Jul 03, 2024 | $0.2648 |
| Mar 20, 2024 | Mar 21, 2024 | Mar 27, 2024 | $0.0403 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 28, 2023 | $0.0384 |
| Dec 22, 2022 | Dec 23, 2022 | Dec 30, 2022 | $0.0199 |
İzleyen dağıtım verimi = son 12 ayın nakdi ÷ güncel fiyat. Bu değer SEC 30 günlük verimi DEĞİLDİR ve dağıtımların devam edeceği garanti edilmez. Farkın açıklaması →
Risk İstatistikleri
| Oynaklık 1Y / 3Y | 43.76% / 42.04% | Sharpe 1Y / 3Y | 2.02 / 1.02 |
| Maks. düşüş 1Y / 3Y | -16.92% / -45.31% | Sortino 1Y | 3.18 |
| S&P 500'e Karşı Beta (3Y) | 1.52 | S&P 500 ile Korelasyon (1Y) | 0.43 |
| Aşağı yönlü sapma 1Y | 27.73% | Kullanılan risksiz faiz oranı | 4.05% (3M T-bill, FRED) |
Hesaplayan: ETF Explorer günlük temettü düzeltmeli kapanışlardan; oynaklık ve düşüş yıllıklandırılmış/dönem rakamlarıdır; S&P 500 maruziyeti SPY ile yakınsanmıştır. İtibarıyla Oct 12, 2026. Formüller →
Likidite
| Bugünkü hacim | 7.33K | Ortalama hacim | 10.96K |
| AUM | $93.2M | Prim/İskonto | +0.02% |
| Alış/Satış farkı | Veri kaynağımız tarafından sağlanmamıştır. Aracı kurumunuzun fiyat ekranını kontrol edin; spreadler açılış ve kapanışta en geniş seviyededir. | ||
Prim/iskonto, gecikmeli piyasa fiyatını son raporlanan NAV ile karşılaştırır: gösterge niteliğinde bir rakam olup resmi kapanış primi/iskontosu değildir. ETF likiditesi nasıl çalışır →
Fon Akışları (tahmini)
| Dönem | Tahmini net akış | Başlangıç AUM'unun %'si | AUM başlangıç → bitiş |
|---|---|---|---|
| 1 Gün | $0.00 | 0.00% | $93.2M → $93.2M |
| 1 Ay | -$3.2M | -3.38% | $95.4M → $93.2M |
| 1 Hafta | $1.9M | +2.05% | $92.2M → $93.2M |
ETF Explorer tahmini: raporlanan AUM'daki değişim eksi piyasa hareketi etkisi; kendi günlük anlık görüntülerimizden hesaplanmıştır. Resmi ihraççı oluşturma/itfa verisi değildir.
Resmi Fon Kaynakları
Resmi Fon Sayfası ↗
ETF İhraççı Web Sitesi (ProShares) ↗
İzahname dosyaları (SEC EDGAR) ↗
Yıllık / Altı aylık raporlar (SEC EDGAR) ↗
Tüm SEC başvuruları ↗
Dış bağlantılar, ihraççının sitesini veya SEC EDGAR'ı yeni bir sekmede açar. İzahname ve resmi belgeler her zaman yetkili kaynaktır; yatırım yapmadan önce incelemeniz önerilir.
Son Haberler: BIB
Son 7 günde bu fonu doğrudan ele alan makale yok; genel ETF haberleri gösteriliyor.
Brian Hartigan on Why Invesco’s QQQ Suite Stands Out Among Competitors ↗
Invesco Global Head of ETFs & Index Strategies Brian Hartigan was on Bloomberg TV on October 5, where he discussed the growth of the firm’s QQQ…
ETF Trends · Oct 12, 11:30 UTC
The $15 Billion Club: Active Income Strategies ↗
Two popular ETFs crossed the $15 billion in assets mark last week. The JPMorgan Core Plus Bond ETF (JCPB) and the NEOS Nasdaq 100 High Income ETF…
ETF Trends · Oct 12, 07:06 UTC
S&P 500 predictions after 2026 midterm elections ↗
With the U.S. midterm elections on the horizon, attention is turning to the S&P 500 and how the benchmark index could react to the polls.
Finbold · Oct 12, 06:55 UTC
Two ETFs, Zero Fees: The 60/40 Retirement Portfolio That Costs Nothing to Own ↗
The 60/40 portfolio looked broken in 2022 when stocks and bonds collapsed together, but rebuilding it today starts from a fundamentally different…
24/7 Wall Street · Oct 12, 04:34 UTC
Why TIP Lost Money in 2022 While Inflation Hit 9%: The Duration Trap Inside Most TIPS ETFs ↗
When inflation surged above 9% in 2022, one of the most popular TIPS ETFs still lost money for its investors, and the reason has nothing to do with…
24/7 Wall Street · Oct 12, 04:24 UTC
Stock Market: Will S&P 500 Open Up or Down Today? ↗
U.S. stock futures point to a strong start to the week on Monday as Wall Street welcomes cooling energy prices and prepares for the official kickoff…
Benzinga · Oct 12, 02:19 UTC
Tüm haberler: BIB →
Rehberli yardım: AUM, fonun büyüklüğüdür. Gider oranı, getirilere yansıyan yıllık maliyettir. NAV, fonun sahip olduğu varlıkların hisse başına değeridir; piyasa fiyatı bu değerin biraz üzerinde (prim) veya altında (iskonto) olabilir. Toplam getiri, dağıtımların yeniden yatırıldığını varsayar. Her veri seti kendi güncelleme tarihini gösterir; çünkü portföy, varlık ve fiyat verileri farklı takvimlerde güncellenir.